Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K-ATP channels


Iskit A. B., Erkent U., Ertunc M., Guc M., Ilhan M., Onur R.

VASCULAR PHARMACOLOGY, cilt.46, sa.2, ss.129-136, 2007 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 46 Sayı: 2
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1016/j.vph.2006.08.415
  • Dergi Adı: VASCULAR PHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.129-136
  • Anahtar Kelimeler: glibenclamide, endotoxin, nateglinide, arrhythmia, nitric oxide, repaglinide, NITRIC-OXIDE SYNTHASE, ISCHEMIA-REPERFUSION ARRHYTHMIAS, SENSITIVE POTASSIUM CHANNELS, DELAYED PROTECTION, INFARCT SIZE, GUINEA-PIGS, RATS, INHIBITORS, TISSUE, HEART
  • Hacettepe Üniversitesi Adresli: Evet

Özet

The role of K-ATP channels in the antiarrhythmic effect of Eschcrichia coli endotoxin-induced nitric oxide synthase (iNOS) was examined in an anesthetised rat model of myocardial ischemia and reperfusion arrhythmia by using glibenclamide (1 mg kg(-1)), nateglinide (10 mg kg(-1)) and repaglinide (0.5 mg kg(-1)). Endotoxin (1 mg kg(-1)) was administered intraperitoneally 4 h before the occlusion of the left coronary artery and glibenclamide, nateglinide or repaglinide was administered 30 min before coronary artery occlusion. We also evaluated the effects of K-ATP channel blockers and nonselective K+ channel blocker tetyaethylammonium (TEA) on cardiac action potential configuration in the atria obtained from endotoxemic rats. The mean arterial blood pressure of rats receiving endotoxin was lower during both the occlusion and reperfusion periods. Endotoxin significantly reduced the total number of ectopic beats and the duration of ventricular tachycardia. Glibenclamide, but not nateglinide and repaglinide, prevented the hypotension and antiarrhythinic effects of endotoxin. Atria obtained from endotoxin-treated rats had prolonged action potential duration. This effect was abolished with pretreatment of iNOS inhibitors, L-canavanine and dexamethasone and perfusion of glibenclamide, but not with TEA and non-sulfonylurea drug, nateglinide. We demonstrated that glibenclamide inhibits the antiarrhythmic effect of endotoxin and this effect does not appear to involve KATP channels. (c) 2006 Elsevier Inc. All rights reserved.